Henning Hoelder

Henning Hoelder is a financial analyst known for his insights into the pharmaceutical industry. His commentary often focuses on market trends and the financial implications of mergers and acquisitions within the sector. Recently, he has been involved in discussions regarding a potential merger between AstraZeneca and Bristol Myers Squibb, which could reshape the landscape of the pharmaceutical market.